Educational activities

Monthly International Seminar Series on Liver Toxicity and Steatotic Liver Disease and different EASL studio topics for DHILI will be organised at a later stage.

As a proposal within our educational activities, we will be launching from January a series of talks on Liver Toxicity and Steatotic Liver Disease, ONCE monthly, given by international experts in the field. The session outline would be a talk of around 45 min with 15 min left for discussion. Conferences will be held on the 3rd Wednesday of each month at 16.30h (CET) starting from January 17^th 2024.

These international seminar series are the result of an outstanding collaboration between the EASL DHILI Consortium (https://easldhiliconsortium.eu/) and the Halt-RONIN (UKRI-Horizon Europe) https://halt-ronin.com/

The objectives are:

• to improve collaboration between different group experts encompassing clinical investigators, researchers, basic scientists, industry partners and regulators.
• To foster scientific progress by disseminating the latest breakthroughs in research on hepatotoxicity and metabolic dysfunction-associated steatotic liver disease

Bernard Fromenty is a research director at INSERM and currently co-directs one of the teams at the NUMECAN Institute in Rennes, France. He has been working for 35 years on liver damage induced by different xenobiotics including drugs, alcohol and environmental toxins. His research aims to determine the mechanisms by which certain xenobiotics can induce different liver lesions with a particular interest for steatosis and steatohepatitis. More specifically, his research focuses on mitochondrial dysfunction, alteration of lipid homeostasis and oxidative stress. More recently, he has extended his research to the issue of hepatotoxicity in the context of obesity and MASLD. He is the co-author of more than 140 original articles and reviews.